PMID- 37152426 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230509 IS - 2352-9067 (Print) IS - 2352-9067 (Electronic) IS - 2352-9067 (Linking) VI - 46 DP - 2023 Jun TI - High medium-term incidence of major cardiovascular events in discharged patients with unstable angina. PG - 101209 LID - 10.1016/j.ijcha.2023.101209 [doi] LID - 101209 AB - The introduction of high-sensitivity troponin (hsTn) assays has reduced the diagnosis of unstable angina (UA) in favor of non-ST elevation myocardial infarction (NSTEMI) in the context of non-ST elevation acute coronary syndrome (NSTEACS). It is unclear whether the detection of these hsTn levels affects the prognosis and therefore whether a different therapeutic approach is warranted. This study aims to determine whether using hsTn results in medium-term prognostic differences in patients with UA and NSTEMI. METHODS: This multicenter, prospective registry study included consecutive patients who underwent hsTn assays and were discharged with a diagnosis of NSTEACS. Patients were followed for two years. Outcomes were the occurrence of major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal ischemic stroke), major bleeding, and all-cause mortality. RESULTS: Patients with UA and NSTEMI did not show differences in terms of the invasive interventions received, the coronary artery disease diagnosed, the type of revascularization performed, or the proportion presenting MACE (UA 18.1% vs. NSTEMI 18.9%; p = 0.79). However, patients with NSTEMI had higher cardiovascular mortality at two years (UA 4% vs. NSTEMI 9.2%; p = 0.012), as well as, all-cause mortality (UA vs. 7.9% vs. NSTEMI 16.4%; p = 0.002). CONCLUSIONS: Medium-term incidence of MACE was similar in patients with UA and NSTEMI, but cardiovascular and all-cause mortality in NSTEMI patients was over twice that of patients with UA. CI - (c) 2023 The Authors. FAU - Herrero-Brocal, Marta AU - Herrero-Brocal M AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. FAU - Marin, Francisco AU - Marin F AD - Department of Cardiology, Hospital Clinico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain. FAU - Valverde, Laura AU - Valverde L AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. FAU - Garcia-Barrios, Ana M AU - Garcia-Barrios AM AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. FAU - Fuertes, Laura AU - Fuertes L AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. FAU - Cambra, Cristina AU - Cambra C AD - Cardiology Department, Torrevieja University Hospital, Alicante, Spain. FAU - Torres-Mezcua, Fernando AU - Torres-Mezcua F AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. FAU - Hortelano, Ignacio AU - Hortelano I AD - Cardiology Department, Hospital Marina Baja de Villajoyosa, Alicante, Spain. FAU - Villamia, Beatriz AU - Villamia B AD - Cardiology Department, Torrevieja University Hospital, Alicante, Spain. FAU - Esteve-Pastor, Maria Asuncion AU - Esteve-Pastor MA AD - Department of Cardiology, Hospital Clinico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain. FAU - Orenes-Pinero, Esteban AU - Orenes-Pinero E AD - Department of Cardiology, Hospital Clinico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain. FAU - Martinez, Juan Gabriel Martinez AU - Martinez JGM AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. FAU - Rivera-Caravaca, Jose Miguel AU - Rivera-Caravaca JM AD - Department of Cardiology, Hospital Clinico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain. FAU - Ruiz-Nodar, Juan M AU - Ruiz-Nodar JM AD - Cardiology Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain. LA - eng PT - Journal Article PT - Review DEP - 20230426 PL - Ireland TA - Int J Cardiol Heart Vasc JT - International journal of cardiology. Heart & vasculature JID - 101649525 PMC - PMC10160493 OTO - NOTNLM OT - High-sensitivity troponin OT - Major adverse cardiovascular events OT - Non-ST elevation myocardial infarction OT - Prognosis OT - Unstable angina COIS- The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: 'This study has been partially supported by a Research Grant from the Spanish Society of Cardiology (SEC).' EDAT- 2023/05/08 06:41 MHDA- 2023/05/08 06:42 PMCR- 2023/04/26 CRDT- 2023/05/08 04:03 PHST- 2023/02/22 00:00 [received] PHST- 2023/04/10 00:00 [revised] PHST- 2023/04/12 00:00 [accepted] PHST- 2023/05/08 06:42 [medline] PHST- 2023/05/08 06:41 [pubmed] PHST- 2023/05/08 04:03 [entrez] PHST- 2023/04/26 00:00 [pmc-release] AID - S2352-9067(23)00040-4 [pii] AID - 101209 [pii] AID - 10.1016/j.ijcha.2023.101209 [doi] PST - epublish SO - Int J Cardiol Heart Vasc. 2023 Apr 26;46:101209. doi: 10.1016/j.ijcha.2023.101209. eCollection 2023 Jun.